What is the MELD score for a patient with elevated bilirubin (hyperbilirubinemia) of 3.59, elevated INR (coagulopathy) of 1.99, and impaired renal function (elevated creatinine) of 1.3?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

MELD Score Calculation

For this patient with bilirubin 3.59 mg/dL, INR 1.99, and creatinine 1.3 mg/dL, the MELD score is 19.

Formula and Calculation

The MELD score uses a logarithmic formula incorporating three objective laboratory values that reflect hepatic excretory function (bilirubin), coagulation function (INR), and renal function (creatinine) 1, 2:

MELD = 3.78 × ln(bilirubin mg/dL) + 11.2 × ln(INR) + 9.57 × ln(creatinine mg/dL) + 6.43 3, 2

For this patient:

  • 3.78 × ln(3.59) = 3.78 × 1.278 = 4.83
  • 11.2 × ln(1.99) = 11.2 × 0.688 = 7.71
  • 9.57 × ln(1.3) = 9.57 × 0.262 = 2.51
  • Constant = 6.43
  • Total MELD = 4.83 + 7.71 + 2.51 + 6.43 = 19.48 ≈ 19

Clinical Interpretation

A MELD score of 19 indicates significant liver disease with approximately 20% risk of 90-day mortality and represents a threshold where liver transplantation evaluation should be strongly considered 3.

Prognostic Significance:

  • MELD ≥18-21 indicates poor prognosis in patients with alcoholic hepatitis and advanced liver disease 3
  • MELD >20 identifies patients at high risk of 90-day mortality in cirrhosis 3
  • MELD ≥15 generally represents the threshold for liver transplant listing consideration 4
  • This score of 19 falls into the intermediate-to-high risk category where 90-day mortality without transplantation is substantial 3, 5

Mortality Risk Stratification:

Studies demonstrate that patients with MELD 19-25 have significantly elevated short-term mortality 3, 6:

  • MELD 19 corresponds to approximately 20% 90-day mortality risk 3
  • MELD >18 shows survival benefit from liver transplantation in Japanese cohorts 5
  • MELD cutoffs maximizing negative predictive value for in-hospital mortality include MELD ≤27, meaning this patient's score of 19 places them in an intermediate risk zone 6

Important Clinical Considerations

Interfering Factors to Verify:

Before finalizing clinical decisions based on this MELD score, confirm the following 2, 7:

  • INR elevation: Ensure the INR of 1.99 reflects liver synthetic dysfunction and not oral anticoagulation therapy (warfarin, direct oral anticoagulants), which would artificially elevate the MELD score 2, 7
  • Creatinine elevation: Verify the creatinine of 1.3 mg/dL represents true renal function and not medication effects (trimethoprim, cimetidine) or acute kidney injury unrelated to hepatorenal syndrome 2, 7
  • Renal insufficiency: Calculate eGFR to determine if creatinine elevation is due to chronic kidney disease rather than liver-related renal dysfunction 7

Additional Prognostic Factors Not Captured by MELD:

MELD deliberately excludes clinical parameters that may significantly impact prognosis 3, 4:

  • Hepatic encephalopathy: Presence and grade significantly increase mortality risk (contributes 42.2% to mortality in decision tree models) 6
  • Ascites: Not included in MELD but captured in Child-Pugh scoring 3, 4
  • Serum sodium: Hyponatremia is an independent predictor of death; MELD-Na may provide better prognostic accuracy in patients with low sodium 2, 6
  • Infection: Admission infections contribute 22.2% to mortality risk in cirrhotic patients 6

MELD Score Range Context:

The MELD score produces a numerical scale from 6 (less ill) to 40 (gravely ill) 3, 1:

  • MELD 6-9: Minimal liver disease
  • MELD 10-14: Moderate liver disease (corresponds approximately to Child-Pugh B) 7
  • MELD 15-20: Severe liver disease requiring transplant evaluation 4, 5
  • MELD 21-27: High mortality risk 6
  • MELD ≥28: Very high mortality risk 6

This patient's MELD of 19 places them in the severe liver disease category where transplant evaluation is warranted and 90-day mortality risk is substantial 3, 5.

References

Guideline

MELD Formula and Applications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

MELD Score Parameters and Calculations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

MELD and Child-Turcotte-Pugh Scoring Systems

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Liver Failure, Hepatic Encephalopathy, and Infection Contribute to Mortality Risk in a Global Cirrhosis Cohort.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2025

Related Questions

What laboratory values are required to calculate a patient's MELD (Model for End-Stage Liver Disease) score and how is it calculated?
What is the MELD (Model for End-Stage Liver Disease) score for a patient with hyperbilirubinemia (bilirubin 2.8 mg/dL), elevated INR (International Normalized Ratio) (1.6), and impaired renal function (creatinine 1.25 mg/dL)?
Can patients with liver failure and a Model for End-Stage Liver Disease (MELD) score of 15 safely take clonazepam and sertraline, and what about propranolol?
Can clonazepam and sertraline be used in a patient with liver failure and a Model for End-Stage Liver Disease (MELD) score of 15?
What parameters are needed to calculate the Model for End-Stage Liver Disease (MELD) score for an adult patient with advanced liver disease?
What is the best course of action to evaluate and manage pelvic pain and a thickened endometrium in a 33-year-old female, 8 months postpartum, without abnormal uterine bleeding?
What is the recommended approach for a central line procedure in a patient with potential bleeding disorders or allergies?
Why would a patient with Multiple Endocrine Neoplasia Type 1 (MEN1) undergo a Technetium-99m (TC99m) sestamibi scan?
What is the appropriate evaluation and management approach for an elderly patient presenting with bloody vaginal discharge, considering potential underlying conditions such as endometrial cancer or atrophy?
What is a suitable blood glucose test for an 11-year-old pediatric patient?
Is a DEXA (Dual-Energy X-ray Absorptiometry) scan appropriate for an 80-year-old female patient with hypertension and potential vitamin D deficiency?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.